OXA-48-like β-lactamases: global epidemiology, treatment options, and development pipeline

SE Boyd, A Holmes, R Peck… - Antimicrobial agents …, 2022 - Am Soc Microbiol
Modern medicine is threatened by the rising tide of antimicrobial resistance, especially
among Gram-negative bacteria, where resistance to β-lactams is most often mediated by β …

Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections

B Isler, AT Aslan, M Akova, P Harris… - Expert review of anti …, 2022 - Taylor & Francis
Introduction OXA-48 and NDM are amongst the most prevalent carbapenemase types
associated with Klebsiella pneumoniae worldwide, with an increase in their prevalence in …

[HTML][HTML] European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram …

M Paul, E Carrara, P Retamar, T Tängdén… - Clinical Microbiology …, 2022 - Elsevier
Scope These ESCMID guidelines address the targeted antibiotic treatment of third-
generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem …

Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and …

JC Ontong, NF Ozioma, SP Voravuthikunchai, S Chusri - Plos one, 2021 - journals.plos.org
Multidrug resistant Enterobacterales have become a serious global health problem, with
extended hospital stay and increased mortality. Antibiotic monotherapy has been reported …

Emergence of Colistin and Carbapenem Resistance in Extended-Spectrum β-Lactamase Producing Klebsiella pneumoniae Isolated from Chickens and Humans in …

W Elmonir, NK Abd El-Aziz, YH Tartor, SM Moustafa… - Biology, 2021 - mdpi.com
Simple Summary Carbapenems and colistin are reserved as the last-resort treatments of
multidrug-resistant (MDR) infections in humans. Consequently, the emergence of …

[HTML][HTML] In vitro activity of ceftazidime/avibactam and comparators against carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa isolates …

P Kiratisin, K Kazmierczak, GG Stone - Journal of Global Antimicrobial …, 2021 - Elsevier
Objectives: This study reports the antimicrobial activity of ceftazidime/avibactam (CZA) and
comparators against carbapenemase-producing Enterobacterales (N= 1992) and …

A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 …

AT Aslan, E Kırbaş, B Sancak, ES Tanrıverdi… - International journal of …, 2022 - Elsevier
This study aimed to characterize the epidemiology and clinical outcomes of patients with
bloodstream infections (BSIs) due to carbapenem-resistant Klebsiella pneumoniae (CRKP) …

Research updates of plasmid-mediated aminoglycoside resistance 16S rRNA methyltransferase

W Yang, F Hu - Antibiotics, 2022 - mdpi.com
With the wide spread of multidrug-resistant bacteria, a variety of aminoglycosides have been
used in clinical practice as one of the effective options for antimicrobial combinations …

In Vitro antibiotic combinations of Colistin, Meropenem, Amikacin, and Amoxicillin/clavulanate against multidrug-resistant Klebsiella pneumonia isolated from patients …

G Bayatinejad, M Salehi, R Beigverdi, S Halimi… - BMC microbiology, 2023 - Springer
Background Hospital infections such as ventilator-associated pneumonia (VAP) due to
multidrug-resistant Klebsiella pneumoniae (MDR-KP) strains have increased worldwide. In …

Emergence of colistin-resistant gram-negative rods in intensive care units: A cross-sectional study from a develo** country

B Syed, S Ishaque, A Imran, O Muslim… - SAGE Open …, 2022 - journals.sagepub.com
Objectives: To determine the clinical features, outcomes, and factors associated with the
emergence of colistin-resistant gram-negative rods isolated from patients admitted to …